This finding is in agreement with data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) study, showing only a minor increase in plasma t-tau in people with AD dementia compared with healthy controls [48], probably because current assay for plasma t-tau captures both brain-derived and peripherally produced tau protein [49]. The gene discussed is MAPT; the disease is Alzheimer disease.